Sign Out
The ADRs derived from clinical studies and post-marketing surveillance with Augmentin, sorted by Med DRA System Organ Class are listed as follows.
The following terminologies have been used in order to classify the occurrence of undesirable effects. Very common (M/10); Common (1/100 to <1/10); Uncommon (21/1,000 to <1/100); Rare (z1/10,000 to <1/1,000); Very rare (<1/10,000); Not known (cannot be estimated from the available data). (See Table.)
Click on icon to see table/diagram/image
View ADR Reporting Link
Continue with Google